Annual report [Section 13 and 15(d), not S-K Item 405]

SCHEDULE OF REVENUE RECOGNITION (Details)

v3.25.4
SCHEDULE OF REVENUE RECOGNITION (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Product Information [Line Items]    
Total net revenue $ 6,161,959 $ 9,362,022
Health Care, Patient Service [Member]    
Product Information [Line Items]    
Total net revenue [1] 4,971,342 8,175,670
Histology Service Fees [Member]    
Product Information [Line Items]    
Total net revenue 1,116,912 1,103,751
Medical Director Fees [Member]    
Product Information [Line Items]    
Total net revenue 68,268 66,576
Department of Defense Observational Studies [Member]    
Product Information [Line Items]    
Total net revenue 577 8,654
Other Revenues [Member]    
Product Information [Line Items]    
Total net revenue $ 4,860 $ 7,371
[1] Patient services fees include direct billing for CyPath® Lung diagnostic test of approximately $963,000 and $516,000 for the years ended December 31, 2025 and 2024.